Similar Articles
411 Radiomics for the detection of microvascular invasion in hepatocellular carcinoma
412 Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”
413 Laparoscopic vs open liver re-resection for cirrhotic patients with post-hepatectomy hepatocellular carcinoma recurrence: A comparative study
414 Providing higher value care for hepatocellular carcinoma rather than diagnosis: What can current radiologists do?
415 Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
416 Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
417 Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography
418 Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis
419 Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study
420 Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA